ArticleCureus2025
Continuous Hemodynamic Monitoring and Goal-Directed Therapy for Optimization in Total Knee Replacement: A Prospective Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Goal-directed fluid therapy (GDT) has become an important strategy for optimizing perioperative hemodynamics by tailoring fluid administration to each patient's individual needs. In this prospective observational study, we evaluated the use of GDT guided by the non-invasive ClearSight monitoring system (Edwards Lifesciences Corporation, Irvine, CA, USA) in patients undergoing total knee arthroplasty (TKA) under spinal anesthesia. Forty patients were included and managed either with a GDT protocol or with standard fluid therapy. Hemodynamic parameters, fluid administration, and early postoperative outcomes were assessed. Patients in the GDT group received significantly less intraoperative crystalloid volume compared to controls and had a shorter stay in the post-anesthesia care unit. Moreover, the GDT group demonstrated more stable mean arterial pressure throughout the procedure. These findings suggest that continuous non-invasive hemodynamic monitoring can enhance intraoperative fluid optimization and improve immediate recovery following orthopedic surgery. Larger randomized trials are necessary to confirm these results and further define the clinical benefits of GDT in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.